PTC Therapeutics
PTCT
#3161
Rank
NZ$6.12 B
Marketcap
$77.71
Share price
-7.02%
Change (1 day)
61.17%
Change (1 year)

P/S ratio for PTC Therapeutics (PTCT)

P/S ratio as of April 2025 (TTM): 4.29

According to PTC Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -3.15. At the end of 2024 the company had a P/S ratio of 4.32.

P/S ratio history for PTC Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20244.3294.97%
20232.22-44.37%
20223.99-23.76%
20215.23-52.2%
202010.912.86%
20199.6947.71%
20186.5684.28%
20173.56-21.36%
20164.53-83.83%
201528.0-62.25%
201474.2475.16%
201312.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
11.2 161.33%๐Ÿ‡บ๐Ÿ‡ธ USA
2.91-32.26%๐Ÿ‡บ๐Ÿ‡ธ USA
5.89 37.33%๐Ÿ‡บ๐Ÿ‡ธ USA
296 6,793.46%๐Ÿ‡บ๐Ÿ‡ธ USA
4.76 10.99%๐Ÿ‡บ๐Ÿ‡ธ USA
4.08-4.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland